| DC Field | Value | Language |
|---|
| dc.contributor.author | Avdeeva, N. V. | - |
| dc.contributor.author | Nikitina, V. A. | - |
| dc.contributor.author | Kochkarova, I. S. | - |
| dc.contributor.author | Litvinova, A. S. | - |
| dc.date.accessioned | 2022-05-05T09:35:55Z | - |
| dc.date.available | 2022-05-05T09:35:55Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | The possibility of administration of glutamate receptors antagonists in the treatment of parkinson's disease / N. V. Avdeeva [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol. 2, № 3.- P. 86-94. - Doi: 10.18413/2500-235X -2016-2-3-86-94. - Refer.: p. 94. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46618 | - |
| dc.description.abstract | Parkinson's disease is the slow-progressing chronic neurodegenerative disease. Modern medicine has not yet found methods of curing disease, however, the existing methods of conservative and surgical treatment significantly improve the patient’s quality of life and slow the progression of the disease | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | neuropathology | ru |
| dc.subject | diseases of the central nervous system | ru |
| dc.subject | Parkinson's disease | ru |
| dc.subject | glutamate receptors | ru |
| dc.subject | basal ganglia | ru |
| dc.subject | NMDA receptors | ru |
| dc.subject | AMPA receptors | ru |
| dc.subject | metabotropic glutamate receptors | ru |
| dc.subject | levodopa-induced dyskinesia | ru |
| dc.title | The possibility of administration of glutamate receptors antagonists in the treatment of parkinson's disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 3
|
